Skip to search.
 All Ordinaries Down 1.04%

More On VLA.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Viralytics Ltd (VLA.AX)

-ASX
1.15 0.00(0.00%) 2 Dec 15:58
Prev Close:1.15
Open:1.15
Bid:1.14
Ask:1.16
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.14 - 1.17
52wk Range:0.62 - 1.35
Volume:695,205
Avg Vol (3m):239,734
Market Cap:276.33M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):59.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Viralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia. Its lead investigational product is CAVATAK, a proprietary formulation of an oncolytic common cold virus that ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback